Advanced search×

Testing a model of change in the experiential treatment of depression.

J Consult Clin Psychol 77(6):1055-66 (2009) PMID 19968382

In this study, we measured emotional processing and the alliance across 3 phases of therapy (beginning, working, and termination) for 74 clients who each received brief experiential psychotherapy for depression. Using path analysis, we proposed and tested a model of relationships between these 2 processes across phases of therapy and how these processes relate to predict improvement in the domains of depressive and general symptoms, self-esteem, and interpersonal problems after experiential treatment. Both therapy processes significantly increased across phases of therapy. Controlling for both client processes at the beginning of therapy, working phase emotional processing was found to directly and best predict reductions in depressive and general symptoms, and it could directly predict gains in self-esteem. Within working and termination phases of therapy, the alliance significantly contributed to emotional processing and indirectly contributed to outcome. Surprisingly, beginning therapy alliance (measured after Session 1) also directly predicted all outcomes. Furthermore, only clients' beginning therapy process predicted reductions in interpersonal problems. Therefore, although the proposed theory of change was supported, clients' beginning therapy processes may constrain clients' success in experiential treatment and in particular their outcomes in some problem domains related to depression.

DOI: 10.1037/a0017059
Version: za2963e q8za4 q8zb0 q8zc7 q8zda q8ze3 q8zfd q8zg4

Similar articles you may find interesting…

  1. Factors associated with reduced efficacy of sitagliptin therapy: analysis of 93 patients with type 2 diabetes treated for 1.5 years or longe...

    J Clin Med Res 5(3):217-21 (2013) PMID 23671547

    Several studies have shown the effectiveness of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for type 2 diabetes, with a hypoglycemic effect being demonstrated both when it is administered alone or in combination with other oral antidiabetic agents. However, there are few reports...
  2. surgical Treatment for Patients with Periodontal Disease Reduce End Stage Renal Disease Risk: A Nationwide Population-Based Retrospective Co...

    J Periodontol (2013) PMID 23646848

    Patients with periodontal disease undergo operation for subgingival curettage and/or periodontal flap have a remarkably decreased risk of ESRD....
  3. Differentially expressed epigenome modifiers, including Aurora kinase A and B, in immune cells of rheumatoid arthritis.

    Arthritis Rheum (2013) PMID 23653330

    Arthritis development is accompanied the changes in the expression of a number of epigenome-modifying enzymes. Drug-induced downregulation of the Aurora kinases, among other targets, seems to be sufficient to treat experimental arthritis. Development of new therapeutics that target the Aurora kinase...